Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

D. Bailey,E. Berry-Kravis,A. Wheeler,M. Raspa,Florence Merrien,J. Ricart,B. Koumaras,G. Rosenkranz,M. Tomlinson,F. von Raison,George G Apostol
DOI: https://doi.org/10.1186/s11689-015-9134-5
2015-12-15
Journal of Neurodevelopmental Disorders
Abstract:
What problem does this paper attempt to address?